IS7816A - Fenýl setin píperdín efnasambönd til notkunar semPPAR hvatar. - Google Patents
Fenýl setin píperdín efnasambönd til notkunar semPPAR hvatar.Info
- Publication number
- IS7816A IS7816A IS7816A IS7816A IS7816A IS 7816 A IS7816 A IS 7816A IS 7816 A IS7816 A IS 7816A IS 7816 A IS7816 A IS 7816A IS 7816 A IS7816 A IS 7816A
- Authority
- IS
- Iceland
- Prior art keywords
- ppar
- catalysts
- phenyl substituted
- piperidine compounds
- substituted piperidine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Endocrinology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Emergency Medicine (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US42950602P | 2002-11-26 | 2002-11-26 | |
PCT/IB2003/005235 WO2004048334A1 (en) | 2002-11-26 | 2003-11-14 | Phenyl substituted piperidine compounds for use as ppar activators |
Publications (1)
Publication Number | Publication Date |
---|---|
IS7816A true IS7816A (is) | 2005-04-20 |
Family
ID=32393563
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IS7816A IS7816A (is) | 2002-11-26 | 2005-04-20 | Fenýl setin píperdín efnasambönd til notkunar semPPAR hvatar. |
Country Status (34)
Country | Link |
---|---|
US (2) | US7199243B2 (is) |
EP (1) | EP1567493B1 (is) |
JP (1) | JP4029091B2 (is) |
KR (2) | KR100875318B1 (is) |
CN (1) | CN100439337C (is) |
AR (1) | AR042131A1 (is) |
AT (1) | ATE425966T1 (is) |
AU (1) | AU2003276596B8 (is) |
BR (1) | BR0316521A (is) |
CA (1) | CA2507465C (is) |
CO (1) | CO5570701A2 (is) |
DE (1) | DE60326752D1 (is) |
DK (1) | DK1567493T3 (is) |
EA (1) | EA008928B1 (is) |
ES (1) | ES2321509T3 (is) |
GT (1) | GT200300258A (is) |
HK (1) | HK1083502A1 (is) |
HR (1) | HRP20050437A2 (is) |
IS (1) | IS7816A (is) |
MA (1) | MA27532A1 (is) |
MX (1) | MXPA05005583A (is) |
NL (1) | NL1024881C2 (is) |
NO (1) | NO20052921L (is) |
NZ (1) | NZ539546A (is) |
PE (1) | PE20040699A1 (is) |
PL (1) | PL378268A1 (is) |
PT (1) | PT1567493E (is) |
SI (1) | SI1567493T1 (is) |
TN (1) | TNSN05146A1 (is) |
TW (1) | TW200424172A (is) |
UA (1) | UA83202C2 (is) |
UY (1) | UY28097A1 (is) |
WO (1) | WO2004048334A1 (is) |
ZA (1) | ZA200503104B (is) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2160001A1 (fr) | 2008-08-28 | 2010-03-03 | Oberthur Technologies | Procédé d'échange de données entre deux entités électroniques |
EP2160002A1 (fr) | 2008-08-28 | 2010-03-03 | Oberthur Technologies | Procédé d'échange de données entre deux entités électroniques |
EP2363825A1 (fr) | 2010-03-04 | 2011-09-07 | Inside Secure | Procédé pour conduire une transaction au moyen d'un dispositif NFC |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SI1567493T1 (sl) * | 2002-11-26 | 2009-06-30 | Pfizer Prod Inc | S fenilom substituirane piperidinske spojine za uporabo kot aktivatorji PPAR |
CA2568009A1 (en) * | 2004-05-25 | 2005-12-08 | Pfizer Products Inc. | Use of ppar agonists to treat ruminants |
WO2005115389A2 (en) * | 2004-05-25 | 2005-12-08 | Pfizer Products Inc. | Specific ppar agonists for treating negative energy balance |
AU2005272389B2 (en) | 2004-08-11 | 2011-08-04 | Kyorin Pharmaceutical Co., Ltd. | Novel cyclic aminobenzoic acid derivative |
EP1819681B1 (en) * | 2004-11-23 | 2009-08-12 | Warner-Lambert Company LLC | 7-(2h-pyrazol-3-yl)-3,5-dihydroxy-heptanoic acid derivatives as hmg co-a reductase inhibitors for the treatment of lipidemia |
EP1862464A4 (en) * | 2005-03-23 | 2010-08-25 | Kyorin Seiyaku Kk | NEW CYCLIC AMINOPHENYL ALKANIC ACID DERIVATIVE |
GB0510141D0 (en) | 2005-05-18 | 2005-06-22 | Addex Pharmaceuticals Sa | Novel compounds B3 |
AU2006282403B2 (en) * | 2005-08-26 | 2011-07-07 | Institute Of Medicinal Molecular Design, Inc. | Derivative having PPAR agonistic activity |
US9173875B2 (en) * | 2006-04-11 | 2015-11-03 | Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center | Treatment for nicotine-induced lung disease using peroxisome proliferator-activated receptor gamma agonists |
ATE496043T1 (de) * | 2006-12-01 | 2011-02-15 | Actelion Pharmaceuticals Ltd | 3-heteroaryl (amino bzw. amido)-1- (biphenyl bzw. phenylthiazolyl) carbonylpiperdinderivate als orexinrezeptor-inhibitoren |
EP2178534A4 (en) * | 2007-07-17 | 2011-03-30 | Merck Sharp & Dohme | SOLUBLE EPOXY HYDROLASE INHIBITORS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND PROCESSING METHODS |
US20100292236A1 (en) | 2007-07-19 | 2010-11-18 | H. Lundbeck A/S | 5-Membered Heterocyclic Amides And Related Compounds |
TW201006816A (en) | 2008-05-15 | 2010-02-16 | Organon Nv | Hexafluoroisopropanol derivatives |
UA107938C2 (en) * | 2009-08-12 | 2015-03-10 | Syngenta Participations Ag | Heterocycles with microbicidal properties |
WO2011037793A1 (en) * | 2009-09-25 | 2011-03-31 | Merck Sharp & Dohme Corp. | Substituted aminopiperidines as dipeptidyl peptidase-iv inhibitors for the treatment of diabetes |
TWI513695B (zh) * | 2009-10-27 | 2015-12-21 | Merck Sharp & Dohme | (1,1,1,3,3,3-六氟-2-羥基丙-2-基)苯基衍生物 |
US20130345392A1 (en) | 2011-03-04 | 2013-12-26 | Pfizer Inc | Edn3-like peptides and uses thereof |
GB201314286D0 (en) | 2013-08-08 | 2013-09-25 | Takeda Pharmaceutical | Therapeutic Compounds |
RU2615769C2 (ru) * | 2015-07-29 | 2017-04-11 | Федеральное Государственное Бюджетное Образовательное Учреждение Высшего Образования "Уфимский Государственный Университет Экономики И Сервиса" | Средство для ингибирования фермента альфа-амилазы |
US20220411372A1 (en) * | 2019-09-20 | 2022-12-29 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Small-molecule inhibitors for the b-catenin/b-cell lymphoma 9 protein-protein interaction |
WO2024022521A1 (zh) * | 2022-07-28 | 2024-02-01 | 南通环聚泰生物科技有限公司 | 靶向BCL9/β-连环蛋白互相作用的小分子化合物 |
Family Cites Families (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2025518A1 (is) * | 1969-06-05 | 1970-12-10 | ||
US4476311A (en) * | 1980-03-12 | 1984-10-09 | The Purdue Frederick Company | Analgesic 4-carboxy-pyrrolidin-2-one compound |
EP0077607A1 (en) * | 1981-09-17 | 1983-04-27 | Beecham Group Plc | N-substituted 3-aryl piperidines and derivatives thereof |
EP0115607A1 (de) * | 1983-01-04 | 1984-08-15 | MERCK PATENT GmbH | Tetrahydrocarbazolderivate |
GB9027023D0 (en) | 1990-12-12 | 1991-01-30 | Wellcome Found | Anti-atherosclerotic aryl compounds |
PT100441A (pt) | 1991-05-02 | 1993-09-30 | Smithkline Beecham Corp | Pirrolidinonas, seu processo de preparacao, composicoes farmaceuticas que as contem e uso |
US5274143A (en) * | 1991-07-23 | 1993-12-28 | Hoffmann-La Roche Inc. | Process for the preparation of (R)-3-hexyl-5,6-dihydro-4-hydroxy-6-undecyl-2H-pyran-2-one and (R)-5,6-dihydro-6-undecyl-2H-pyran-2,4(3H)-dione |
AU2869092A (en) | 1991-10-11 | 1993-05-03 | Smithkline Beecham Corporation | Heterocyclic 3-phenylpyrrolidin-2-ones, their preparation and use for the manufacture of a medicament for inhibiting tumor necrosis factor production |
WO1993012086A1 (en) * | 1991-12-11 | 1993-06-24 | Ss Pharmaceutical Co., Ltd. | Arylamide derivative |
JPH05255089A (ja) * | 1991-12-18 | 1993-10-05 | Sanwa Kagaku Kenkyusho Co Ltd | 抗ウイルス剤 |
JP3233991B2 (ja) * | 1992-06-26 | 2001-12-04 | 株式会社ソフィア | 遊技機 |
CA2110095A1 (en) * | 1992-12-08 | 1994-06-09 | Teruo Komoto | Arylamide derivatives |
AU3138595A (en) | 1994-07-20 | 1996-02-16 | Acea Pharmaceuticals, Inc. | Haloperidol analogs and the use thereof |
GB9606805D0 (en) | 1996-03-30 | 1996-06-05 | Glaxo Wellcome Inc | Medicaments |
DE19614204A1 (de) * | 1996-04-10 | 1997-10-16 | Thomae Gmbh Dr K | Carbonsäurederivate, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung |
JPH09312086A (ja) * | 1996-05-22 | 1997-12-02 | Matsushita Electric Ind Co Ltd | 光ディスク再生システム、光ディスク再生方法および光ディスク |
EP0930882A2 (en) | 1996-08-02 | 1999-07-28 | Institut Pasteur De Lille | Prevention or treatment of type 2 diabetes or cardiovascular disease with ppar modulators |
IT1286497B1 (it) * | 1996-11-20 | 1998-07-15 | Italfarmaco Sud Spa | Difosfine di tipo misto eteroariliche-ariliche come leganti chirali, relativi complessi con metalli di transizione e impiego di detti |
WO1999032465A1 (en) * | 1997-12-19 | 1999-07-01 | Merck & Co., Inc. | Arylthiazolidinedione derivatives |
ATE273970T1 (de) * | 1998-04-16 | 2004-09-15 | Pfizer Prod Inc | N-acyl und n-aroyl aralkylamide |
US6376494B1 (en) * | 1998-06-15 | 2002-04-23 | American Home Products Corporation | Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents |
HN1999000149A (es) | 1998-09-09 | 2000-01-12 | Pfizer Prod Inc | Derivados de 4,4-biarilpiperidina |
GB9822473D0 (en) | 1998-10-16 | 1998-12-09 | Glaxo Group Ltd | Chemical compounds |
US6303637B1 (en) * | 1998-10-30 | 2001-10-16 | Merck & Co., Inc. | Heterocyclic potassium channel inhibitors |
CA2324330A1 (en) * | 1999-11-08 | 2001-05-08 | Ssp Co., Ltd. | 4-hydroxy-4-phenylpiperidine derivatives and pharmaceuticals containing the same |
US20020045613A1 (en) | 2000-04-27 | 2002-04-18 | Heinz Pauls | 1-aroyl-piperidinyl benzamidines |
WO2001085716A1 (en) | 2000-05-11 | 2001-11-15 | Kyowa Hakko Kogyo Co., Ltd | 2-piperidone compounds for the treatment of cancer |
MXPA02011400A (es) | 2000-05-22 | 2003-05-23 | Aventis Pharm Prod Inc | Derivados de arimetilamina para uso como inhibidores de triptasa. |
WO2002028834A1 (en) | 2000-10-06 | 2002-04-11 | Smithkline Beecham P.L.C. | Process for the preparation of aryl-piperidine carbinols and intermediates thereof |
TW579375B (en) | 2000-10-12 | 2004-03-11 | Ssp Co Ltd | 2,2-Diphenylbutanamide derivatives and medicines containing the same |
JP2002173426A (ja) | 2000-12-05 | 2002-06-21 | Ss Pharmaceut Co Ltd | 血糖低下剤 |
MXPA03007284A (es) * | 2001-02-15 | 2003-12-04 | Pfizer Prod Inc | Agonistas de receptor activador del proliferador de peroxisomas. |
EP1361878A1 (en) * | 2001-02-15 | 2003-11-19 | Neurosearch A/S | Treatment of parkinson's disease by the combined action of a compound with neurotrophic activity and a compound enhancing the dopamine activity |
SI1567493T1 (sl) * | 2002-11-26 | 2009-06-30 | Pfizer Prod Inc | S fenilom substituirane piperidinske spojine za uporabo kot aktivatorji PPAR |
-
2003
- 2003-11-14 SI SI200331552T patent/SI1567493T1/sl unknown
- 2003-11-14 ES ES03811832T patent/ES2321509T3/es not_active Expired - Lifetime
- 2003-11-14 KR KR1020077012457A patent/KR100875318B1/ko not_active IP Right Cessation
- 2003-11-14 PL PL378268A patent/PL378268A1/pl not_active Application Discontinuation
- 2003-11-14 UA UAA200505008A patent/UA83202C2/ru unknown
- 2003-11-14 PT PT03811832T patent/PT1567493E/pt unknown
- 2003-11-14 EP EP03811832A patent/EP1567493B1/en not_active Expired - Lifetime
- 2003-11-14 MX MXPA05005583A patent/MXPA05005583A/es active IP Right Grant
- 2003-11-14 DE DE60326752T patent/DE60326752D1/de not_active Expired - Lifetime
- 2003-11-14 AT AT03811832T patent/ATE425966T1/de not_active IP Right Cessation
- 2003-11-14 CN CNB200380104275XA patent/CN100439337C/zh not_active Expired - Fee Related
- 2003-11-14 CA CA002507465A patent/CA2507465C/en not_active Expired - Fee Related
- 2003-11-14 KR KR1020057009389A patent/KR100760055B1/ko not_active IP Right Cessation
- 2003-11-14 BR BR0316521-3A patent/BR0316521A/pt not_active IP Right Cessation
- 2003-11-14 NZ NZ539546A patent/NZ539546A/en unknown
- 2003-11-14 DK DK03811832T patent/DK1567493T3/da active
- 2003-11-14 EA EA200500629A patent/EA008928B1/ru not_active IP Right Cessation
- 2003-11-14 JP JP2004554809A patent/JP4029091B2/ja not_active Expired - Fee Related
- 2003-11-14 AU AU2003276596A patent/AU2003276596B8/en not_active Ceased
- 2003-11-14 WO PCT/IB2003/005235 patent/WO2004048334A1/en active Application Filing
- 2003-11-24 AR ARP030104332A patent/AR042131A1/es unknown
- 2003-11-24 US US10/720,942 patent/US7199243B2/en not_active Expired - Fee Related
- 2003-11-25 TW TW092133036A patent/TW200424172A/zh unknown
- 2003-11-25 PE PE2003001197A patent/PE20040699A1/es not_active Application Discontinuation
- 2003-11-26 NL NL1024881A patent/NL1024881C2/nl not_active IP Right Cessation
- 2003-11-26 UY UY28097A patent/UY28097A1/es not_active Application Discontinuation
- 2003-11-26 GT GT200300258A patent/GT200300258A/es unknown
-
2005
- 2005-04-18 ZA ZA200503104A patent/ZA200503104B/en unknown
- 2005-04-20 IS IS7816A patent/IS7816A/is unknown
- 2005-05-16 HR HR20050437A patent/HRP20050437A2/hr not_active Application Discontinuation
- 2005-05-19 CO CO05048657A patent/CO5570701A2/es not_active Application Discontinuation
- 2005-05-26 TN TNP2005000146A patent/TNSN05146A1/fr unknown
- 2005-05-26 MA MA28299A patent/MA27532A1/fr unknown
- 2005-06-15 NO NO20052921A patent/NO20052921L/no not_active Application Discontinuation
-
2006
- 2006-03-20 HK HK06103485.0A patent/HK1083502A1/xx not_active IP Right Cessation
-
2007
- 2007-03-30 US US11/694,337 patent/US20070191429A1/en not_active Abandoned
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2160001A1 (fr) | 2008-08-28 | 2010-03-03 | Oberthur Technologies | Procédé d'échange de données entre deux entités électroniques |
EP2160002A1 (fr) | 2008-08-28 | 2010-03-03 | Oberthur Technologies | Procédé d'échange de données entre deux entités électroniques |
EP2363825A1 (fr) | 2010-03-04 | 2011-09-07 | Inside Secure | Procédé pour conduire une transaction au moyen d'un dispositif NFC |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IS7816A (is) | Fenýl setin píperdín efnasambönd til notkunar semPPAR hvatar. | |
ATE525377T1 (de) | Imidazoä1,5-aüpyrazine als inhibitoren von tyrosinkinase | |
NO20054005D0 (no) | Nye arylpiperazinylforbindelser | |
IS7471A (is) | Ný efnasambönd | |
IS7879A (is) | Ný efnasambönd | |
IS8108A (is) | Ný efnasambönd | |
NO20052884D0 (no) | Substituerte indolpyridinforbindelser som anti-infeksjonsmidler. | |
SE0302305D0 (sv) | Novel Compounds | |
ATE477257T1 (de) | Piperidinylamino-thienoä2,3-dü- pyrimidinverbindungen | |
DK1677623T3 (da) | Tyggeemne til kæledyr | |
IS8228A (is) | Ný asetídínefnasambönd | |
IS7827A (is) | Ný efnasambönd | |
IS8292A (is) | Ný efnasambönd | |
NO20055750D0 (no) | Nye kjemiske forbindelser | |
NO20053753D0 (no) | Karboksylsyreforbindelser. | |
NO20051500D0 (no) | Substituerte heterocyklylpyrimidiner. | |
SE0303452D0 (sv) | New compounds | |
ATE394370T1 (de) | Von vitamin d abgeleitete monohalogenvinylverbindungen | |
DE60325768D1 (de) | Substituierte aralkyl verbindungen | |
SE0202908D0 (sv) | New compounds | |
SE0201925D0 (sv) | New compounds | |
SE0200523D0 (sv) | New compounds | |
SE0202181D0 (sv) | New compounds | |
SE0203751D0 (sv) | New Compounds | |
SE0203122D0 (sv) | New Compounds |